; and (5) receive updates on private sector and international efforts to include pregnant and lactating women in clinical research. (c) Membership (1) In general The Committee shall be composed of— (A) the Federal members listed in paragraph (2); and (B) the non-Federal members appointed pursuant to paragraph (3). (2) Federal members The Federal members of the Committee shall consist of the following Federal officials (or their designees): (A) The Director of the Centers for Disease Control and Prevention. (B) The Director of the National Institutes of Health, the Director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the Director of the Office of Research on Women’s Health of the National Institutes of Health, and the directors of such other national research institutes and national centers of the National Institutes of Health as the Secretary determines appropriate. (C) The Commissioner of Food and Drugs. (D) The Director of the Agency for Healthcare Research and Quality. (E) The Director of the Office on Women’s Health of the Department of Health and Human Services. (F) The Director of the National Vaccine Program. (G) The Director of the Office for Human Research Protections of the Department of Health and Human Services. (H) The Administrator of Health Resources and Services Administration. (I) The head of any other research-related agency or department not described in subparagraphs (A) through (H) as the Secretary determines appropriate, which may include the Department of Veterans Affairs and the Department of Defense. (3) Non-Federal members (A) In general The non-Federal members of the Committee shall consist of— (i) representatives from relevant medical societies with subject matter expertise on pregnant women, lactating women, or children; (ii) representatives from nonprofit organizations with expertise related to the health of women and children; (iii) relevant industry representatives